When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 19 Sep 2025
Last updated: 08 Oct 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • disturbed cognition during event (confusional arousals, sleep terrors, sleepwalking)
  • vigorous activity or violent behaviour (confusional arousals, sleepwalking, sleep terrors, and rapid eye movement sleep behaviour disorder)
  • episodes of inability to move (recurrent isolated sleep paralysis)
  • autonomic hyperactivity during event (sleep terrors)
  • amnesia
  • normal physical examination between episodes

Other diagnostic factors

  • abnormal demeanour and facial expression (confusional arousals, sleepwalking, sleep terrors)
  • evidence of injuries

Risk factors

  • family history of non-rapid eye movement parasomnias (confusional arousals, sleepwalking, sleep terrors)
  • presence of HLA gene DQB1*05 and *04 alleles (non-rapid eye movement [NREM] parasomnias)
  • use of certain drugs
  • alcohol use
  • history of psychiatric disorder
  • fever
  • acute sleep deprivation or irregular sleep-wake schedule disorder
  • emotional stress and traumatic life events
  • forced awakenings
  • untreated comorbid sleep disorders
  • premenstrual state (in adolescent girls)

Diagnostic investigations

1st investigations to order

  • clinical examination
  • polysomnography (rapid eye movement sleep behaviour disorder)

Investigations to consider

  • polysomnography (confusional arousals)
  • polysomnography (sleepwalking)
  • polysomnography (sleep terrors)
  • polysomnography (nightmare disorder)
  • polysomnography (all other parasomnias)
  • polysomnography with expanded electroencephalogram (EEG) video recording
  • urine drug screen

Treatment algorithm

Contributors

Authors

Lourdes M. DelRosso, MD, PhD

Professor of Internal Medicine

University of California San Francisco, Fresno

Medical Director, Sleep Disorders Center

San Francisco

CA

Disclosures

LMD declares that she has no competing interests.

Gulcin Benbir Senel, MD

Professor of Neurology

Department of Neurology

Cerrahpasa Faculty of Medicine

Istanbul University-Cerrahpasa

Istanbul

Türkiye

Disclosures

GBS declares that she has received research funding from Sinada Home, and speaker honoraria from Abdi Ibrahim and Respitek.

Acknowledgements

Dr Lourdes M. DelRosso and Dr Gulcin Benbir Senel would like to gratefully acknowledge Dr Shalini Paruthi, Dr Raman Malhotra, and Dr Alon Y. Avidan, previous contributors to this topic.

Disclosures

SP receives royalties from UpToDate for writing two topics, diagnosis, and management of paediatric obstructive sleep apnoea and is a board member of the Restless Legs Syndrome Foundation. RM declared that he had no competing interests. AYA has been paid honorarium speaking fees by the American Academy of Sleep Medicine, the American Academy of Neurology, the American College of Chest Physicians, Sepracor Inc, Cephalon Inc, and Pfizer Pharmaceuticals.

Peer reviewers

Paul Gringras, MB, ChB, MSc, MRCPCH

Consultant in Paediatric Neurodisability

Evelina Children's Hospital

St Thomas' Hospital

London

UK

Disclosures

PG is lead applicant on the ongoing MENDS trial, which is concerned with the use of melatonin in children with neurodevelopmental disorders and impaired sleep.

Paul Montgomery, MSc, DipSW, DPhil

Reader in Psycho-Social Intervention

Centre for Evidence Based Intervention

Barnett House

University of Oxford

Oxford

UK

Disclosures

PM has received funding greater than 6 figures USD from the Swedish Board of Health and Welfare, Martek Biosciences, Danish Social Research Institute, UK Department of Health, UK Health Technology Assessment Programme. PM declares that he has no competing interests.

Lynn A. D'Andrea, MD

Associate Professor of Pediatrics

Chief

Division of Pulmonary and Sleep Medicine

Department of Pediatrics

Medical College of Wisconsin

Medical Director

Pulmonary Clinic

Children's Hospital of Wisconsin

Milwaukee

WI

Disclosures

LAD declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

American Academy of Sleep Medicine. The AASM international classification of sleep disorders - third edition, text revision (ICSD-3-TR). Jun 2023 [internet publication].Full text

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. text revision, (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022

Mainieri G, Loddo G, Provini F, et al. Diagnosis and management of NREM sleep parasomnias in children and adults. Diagnostics (Basel). 2023 Mar 27;13(7):1261.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer